MAZZARINO, Maria Clorinda
 Distribuzione geografica
Continente #
NA - Nord America 5.918
AS - Asia 2.346
EU - Europa 2.215
SA - Sud America 417
AF - Africa 336
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 5
Totale 11.244
Nazione #
US - Stati Uniti d'America 5.727
SG - Singapore 1.190
RU - Federazione Russa 730
CN - Cina 700
UA - Ucraina 413
IE - Irlanda 368
BR - Brasile 349
IT - Italia 190
CI - Costa d'Avorio 187
VN - Vietnam 182
CA - Canada 157
FR - Francia 121
NL - Olanda 114
DE - Germania 78
SE - Svezia 64
NG - Nigeria 51
IN - India 50
GB - Regno Unito 45
SN - Senegal 44
KR - Corea 37
AR - Argentina 29
HK - Hong Kong 26
MX - Messico 25
PL - Polonia 22
IQ - Iraq 21
ZA - Sudafrica 21
BD - Bangladesh 20
CH - Svizzera 14
IR - Iran 14
TR - Turchia 14
ID - Indonesia 12
UZ - Uzbekistan 12
AT - Austria 11
CO - Colombia 11
EC - Ecuador 11
JP - Giappone 11
ES - Italia 9
KE - Kenya 9
MA - Marocco 9
PK - Pakistan 8
EU - Europa 7
SA - Arabia Saudita 7
GR - Grecia 6
BE - Belgio 5
MY - Malesia 5
PH - Filippine 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
BY - Bielorussia 4
CR - Costa Rica 4
DZ - Algeria 4
FI - Finlandia 4
JO - Giordania 4
VE - Venezuela 4
AZ - Azerbaigian 3
KZ - Kazakistan 3
LT - Lituania 3
NP - Nepal 3
NZ - Nuova Zelanda 3
OM - Oman 3
PS - Palestinian Territory 3
TN - Tunisia 3
AU - Australia 2
CL - Cile 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
EG - Egitto 2
IL - Israele 2
LB - Libano 2
MT - Malta 2
PA - Panama 2
PE - Perù 2
RS - Serbia 2
UY - Uruguay 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BW - Botswana 1
CD - Congo 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
GY - Guiana 1
JM - Giamaica 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
PT - Portogallo 1
RO - Romania 1
TH - Thailandia 1
TW - Taiwan 1
Totale 11.244
Città #
Dallas 1.122
Singapore 706
Santa Clara 677
Jacksonville 494
Chandler 405
Dublin 368
Moscow 318
Houston 316
San Jose 234
Chicago 223
Ashburn 219
Abidjan 187
Boardman 180
Nanjing 117
Beijing 116
Toronto 112
Amsterdam 108
Cambridge 108
Lawrence 107
Andover 106
Lauterbourg 100
Los Angeles 91
Des Moines 78
San Mateo 67
Catania 65
Ho Chi Minh City 63
Hefei 51
Grafing 47
Wilmington 46
Dakar 44
Council Bluffs 42
Hanoi 39
New York 37
Buffalo 36
Seoul 36
Hebei 35
Nanchang 35
Abuja 32
Saint Petersburg 30
São Paulo 30
The Dalles 27
Columbus 25
Jiaxing 25
Orem 23
Hong Kong 22
Shenyang 22
San Francisco 20
Civitanova Marche 19
Tianjin 17
Changsha 16
Florence 15
Lagos 15
Montreal 15
Ottawa 15
Warsaw 15
Boston 14
Chennai 14
Rio de Janeiro 14
Ardabil 13
Brooklyn 13
Johannesburg 13
Leawood 13
Atlanta 12
Augusta 12
Stockholm 12
Bremen 11
London 11
Tokyo 11
Baghdad 10
Da Nang 10
Denver 10
Kunming 10
Norwalk 10
Seattle 10
Monmouth Junction 9
Mumbai 9
Hangzhou 8
Nairobi 8
Ningbo 8
Porto Alegre 8
Curitiba 7
Guangzhou 7
Haiphong 7
Jinan 7
Mexico City 7
Belo Horizonte 6
Erbil 6
Falls Church 6
Redondo Beach 6
Tashkent 6
Washington 6
Ankara 5
Brussels 5
Campinas 5
Goiânia 5
Jakarta 5
Misterbianco 5
Shanghai 5
Amman 4
Biên Hòa 4
Totale 7.905
Nome #
Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders 413
The sex bias in systemic sclerosis: on the possible mechanisms underlying the female disease preponderance 322
Advances in targeting signal transduction pathways. 243
Absence of BRAF gene mutation in non-melanoma skin tumors 217
All trans retinoic acid sensitizes colon cancer cells to hyperthermia cytotoxic effects 169
Analysis of hepatitis C virus infection among health-care workers: an observational study 168
Altered pattern of circulating matrix metalloproteinases -2,- 9 and tissue inhibitor of metalloproteinase -2 in patients with HCV-related chronic hepatitis. Relationship to histological features 163
Activation of the Osteopontin/Matrix Metalloproteinase-9 Pathway Correlates with Prostate Cancer Progression 161
Analysis of BRAF mutation in primary and metastatic melanoma 159
Autosomal recessive hypercholesterolemia in a Sicilian kindred harboring the 432insA mutation of the ARH gene 158
Effect of levofloxacin treatment on semen hyperviscosity in chronic bacterial prostatitis patients 154
Association between rs2294020 in X-linked CCDC22 and susceptibility to autoimmune diseases with focus on systemic lupus erythematosus 153
Analysis of G(-174) CIL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease 151
Beta-2-glycoprotein I is growth regulated and plays a role as survival factor for hepatocytes 149
Association of TIMP-1 +372 SNP with digital ulcer manifestation in female systemic sclerosis patients 144
Detection of BRAF gene mutation in primary choroidal melanoma tissue 139
BRAF G469S mutation as indicator of neoplastic transformation in workers with UV exposure 139
B-cell neoplasia in the context of HCV infection: A distinct entity? 139
Analysis of MMP-9 gene polymorphism 1562C/T in patients suffering from systemic sclerosis with and without ulcers 135
Analysis of matrix metalloproteinase-9 gene polymorphism-1562 C/T in patients suffering from systemic sclerosis with and without ulcers 131
Biological therapy downregulates the heterodimer S100A8/A9 (calprotectin) expression in psoriatic patients 130
Proinflammatory circulating molecules in peripheral arterial disease 128
Analysis of osteopontin and matrix metalloproteinase-9 in prostate cancer 128
Co-regulated expression of matrix metalloproteinase-2 and transforming growth factor-beta in melanoma development and progression 126
Defective function of the fas apoptotic pathway in type 1 diabetes mellitus correlates with age at onset 125
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response 119
Behavior of complement and anti-complement factors in the course of hepatic regeneration and degeneration 119
CD155/Neel-5 immunolocallization in melanocytic skin lesions 118
IL-2 RECEPTORS, NK AND LAK CYTOTOXICITY OF LYMPHOCYTES IN BREAST-CARCINOMA DURING PROLONGED THYMOPENTIN THERAPY 117
Matrix metalloproteinases and their inhibitors as markers of inflammation and fibrosis in chronic liver disease 115
Role of BRAF mutations in hematopoietic malignancies and the induction of cytokine-independence-synergy with PI3K/Akt pathway 112
Liver immunolocalization and plasma levels of MMP-9 in non-alcoholic steatohepatitis (NASH) and hepatitis C infection 112
Soluble adhesion molecules and cytokines in children affected by recurrent infections of the upper respiratory tract 111
Biologically induced improvement of PASI score is associated with a decline of S100A7 expression in psoriatic skin lesions. A preliminary immunohistochemical study 110
Biological therapy induces expression changes in Notch pathway in psoriasis 109
Vitamin D3: an ever green molecule 108
Efficacy of an analysis of lymphocyte subsets in predicting the clinical response to alpha-interferon therapy in thalassaemia patients with chronic infection by hepatitis C virus: a pilot study 108
Analysis of TIMP-1 gene polymorphisms in Italian sclerodermic patients 104
Contribution of Immunohistochemistry in Revealing S100A7/JAB1 Colocalization in Psoriatic Epidermal Keratinocyte 103
Role of Hypoxia and Autophagy in MDA-MB-231 Invasiveness 102
Computational Evaluation of Yin Yang 1 Transcript Levels in the Spectrum of B-cell Neoplasia 102
S100A7, Jab1, and p27 kip1 expression in psoriasis and S100A7 CRISPR-activated human keratinocyte cell line 102
Plasma levels and zymographic activities of matrix metalloproteinases 2 and 9 in type II diabetics with peripheral arterial disease 100
IL2 and its receptors in elderly subjects on hemodialysis 98
Jagged-1 expression is downregulated in skin from biologic-treated psoriatic patients 98
CD155/Necl-5 immunolocalization in melanocytic skin lesions 98
GIT-27 NO may be a potential therapeutic agent for melanoma treatment by inhibition of the transcription repressor YIN-YANG 97
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging 97
S100A7: A rAMPing up AMP molecule in psoriasis 95
IL-1beta, TNF-alpha and IL-6 release from monocytes in haemodialysis patients in relation to dialytic age 94
Osteopontin/Matrix metalloproteinases pathway is not activated in cervical carcinoma 93
Role of tissue inhibitor of metalloproteinases-1 in the development of autoimmune lymphoproliferation 93
Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance 93
Sensitization of cancer stem cells based on inhibiting key signal transduction pathways 92
Effect of alpha-interferon on natural killer cell activity and lymphocyte subsets in thalassemia patients with chronic hepatitis C 91
IL-18 nelle infezioni virali ricorrenti in età pediatrica 91
Osteopontin gene haplotypes correlate with multiple sclerosis development and progression 91
FOXP3, ICOS and ICOSL gene polymorphisms in systemic sclerosis: FOXP3 rs2294020 is associated with disease progression in a female Italian population 91
Evaluation of circulating CD4⁺CD25⁺ and liver-infiltrating Foxp3⁺ cells in HCV-associated liver disease 89
High circulating levels of cytockines (IL6 and TNFα), adhesion molecules (VICAM-1 and ICAM-1) and selectines in patients with peripheral arterial disease at rest and after a treadmill-test 88
Treatment with rapamycin ameliorates clinical and histological signs of protracted relapsing experimental allergic encephalomyelitis in Dark Agouti rats and induces expansion of peripheral CD4+CD25+Foxp3+ regulatory T cells 88
Persistent high plasma levels of interleukins 18 and 4 in children with recurrent infections of the upper respiratory tract 87
Obesity, Type 1 Diabetes, and Psoriasis: An Autoimmune Triple Flip 87
Isoproterenol modulates matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor-2 (TIMP-2) in rat parotid gland 86
Rituximab for treatment of lymphoproliferative disorders associated with hepatitis C virus (HCV) infection 86
Expression and localisation of osteopontin and prominin-1 (CD133) in patients with endometriosis 85
Effects of ischaemic stress on leukocyte activation processes in patients with chronic peripheral occlusive arterial disease: Role of L-propionyl carnitine administration 85
Regulation of drug and immune resistance by YY1 in cancer 84
Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer 84
Inhibition of GSK-3 beta activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in breast cancer 84
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health 84
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance. 83
Genetic polymorphisms of FOXP3 in Italian patients with systemic sclerosis 82
Jagged-1/Notch-1/Hes-1 pathway in psoriatic patients: effects of biological therapy 82
Long pentraxin 3: a marker of inflammation in untreated psoriatic patients 81
Expression and localization of prominin-1 in isoproterenol-treated rat parotid gland 81
CIRCULATING IMMUNOCOMPLEXES AND LARYNGEAL CARCINOMA 80
MAPK and AKT pathways are activated in melanoma by BRAF, NRAS and PIK3CA mutations 80
Insight into the role of microRNAs in brain tumors (review) 79
Isoproterenol treatment modulates matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor-2 (TIMP-2) expression in rat parotid gland 79
Uterine cervical carcinoma: Role of matrix metalloproteinases (Review) 78
High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation 78
Novel NO-donating compound GIT-27NO possesses strong tumoricidal capacity in vitro and in vivo 78
Immunohistocemical localization of NECL-5 in melanocytic skin lesions. Preliminary observations 78
Dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappa B inhibitor, prevents inflammatory injury induced by interferon-gamma and histamine in NCTC 2544 keratinocytes 77
Preoperative rIL-2 treatment in renal cancer: Early and late effects on lymphocyte subsets and proliferation, NK activity, IL-6 in vivo and in vitro production 77
Osteopontin and matrix metalloptroteinase-9 as markers of early detection of prostate cancer development 76
Hormones are key actors in gene x environment interactions programming the vulnerability to Parkinson's disease: glia as a common final pathway 76
Venous stasis causes release of interleukin 1β (IL - 1β), interleukin 6 (IL – 6) and tumor necrosis factor alpha (TNFα) by monocite macrophage 76
Effects of adalimumab, etanercept and ustekinumab on the expression of psoriasin (S100A7) in psoriatic skin 76
S100A7 in psoriasis: Immunodetection and activation by CRISPR technology 76
Understanding rituximab function and resistance: implications for tailored therapy 74
Modulation of Chitotriosidase During Macrophage Differentiation 74
Lack of association of rs3761549 and rs5902434 polymorphisms of FOXP3 gene with risk of systemic sclerosis in the Italian population: A case-control study 72
Detection of bcl-2 rearrangement in mucosa-associated lymphoid tissue lymphomas from patients with hepatitis C virus infection 71
Preventive and curative effects of cyclophosphamide in an animal model of Guillain Barre syndrome 71
Immunolocalization of FOXP3 in HCV-infected liver biopsies. Preliminary observations 70
Prognostic significance of YY1 in High Grade Lymphomas 70
Frequency of bcl-2/IgH translocation in patients with non-Hodgkin's lymphoma and chronic hepatitis C virus infection 70
Nectin like-5 overexpression correlates with the malignant phenotype in cutaneous melanoma 65
Totale 10.954
Categoria #
all - tutte 35.294
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.294


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021201 0 0 0 0 0 0 0 0 0 0 179 22
2021/2022793 102 107 0 8 126 6 113 24 75 0 15 217
2022/20231.167 117 53 20 105 124 212 2 202 269 12 40 11
2023/2024500 22 75 22 42 11 122 1 51 9 7 85 53
2024/20252.170 21 446 100 49 499 282 30 81 186 179 144 153
2025/20264.567 296 340 1.064 322 696 812 502 79 292 164 0 0
Totale 11.378